Health Ministry buys 30 doses of COVID-19 vaccine from Biological-E for Rs 1,500 cr-India News, Firstpost

0


The vaccine was recently approved for phase 3 clinical trials after showing promising results in phases 1 and 2.

Health workers administer the covid-19 vaccine to men during a special vaccination campaign on the grounds of a public school in Hyderabad, India on Sunday, May 30, 2021. (AP Photo / Mahesh Kumar) A.)

The Federal Ministry of Health has finally made an arrangement with Biological-E, a vaccine manufacturer based in Hyderabad. COVID-19 (novel coronavirus infection) Prepaid vaccine dose of Rs 1500 crore. These vaccines will be manufactured and stored by Biological-E from August to December of this year, a ministry statement said on Thursday. COVID-19 (novel coronavirus infection) The Biological-E vaccine is currently in phase 3 clinical trials after showing promising results in phase 1 and phase 2 trials. The vaccine developed by Biological-E is an RBD protein subunit vaccine which could be available in the coming months.

The Biological-E proposal has been reviewed and recommended for due diligence approval by a national expert group on vaccine management. COVID-19 (novel coronavirus infection) (NEGVAC), according to the press release.

He said the deal with Biological-E is part of the Centre’s broader efforts to encourage indigenous vaccine makers by providing support and financial backing for research and development.

Biological-E COVID vaccine candidates are supported by the Center for Preclinical Studies in Phase 3 studies.

The biotechnology division has not only provided financial support in terms of grants of over Rs 1 billion, but has also partnered with Biological-E to partner with the Translational Health Sciences Institute of Technology. (THSTI), Faridabad.

This is the “COVID Mission Slaksha, Indians COVID-19 (novel coronavirus infection) Launched to strengthen and accelerate the “Vaccine Development Mission” COVID-19 (novel coronavirus infection) According to the statement, vaccine development efforts under the third stimulus package, Atmanirbhar 3.0.

The mission is to provide citizens with safe, efficient and affordable accessibility. COVID-19 (novel coronavirus infection) vaccine.The mission is to support the development of 5-6 COVID-19 (novel coronavirus infection) Vaccine candidate. Some of them are currently in the process of authorizing and implementing public health systems.

Not just accelerated COVID-19 (novel coronavirus infection) In addition to vaccine development efforts, we have also fostered a robust end-to-end vaccine development ecosystem in the country that can be used for other ongoing and future research and development activities of other vaccines.

Read again: Hyderabad-based Biological E makes COVID 19 vaccine from Canadian company Providence

Ministry of Health buys 30 doses of COVID-19 vaccine from Biological-E for Rs 1,500 cr-India News, Firstpost Source link Ministry of Health buys 30 doses of COVID-19 vaccine from Biological-E for Rs 1,500 cr-India News, Firstpost



Source link

Leave A Reply

Your email address will not be published.